Biocon Biologics

Biocon Biologics completely acquires Viatris’s global biosimilars business

Read more

Biocon Biologics outlicenses two biosimilar assets to Yoshindo for commercialisation in Japan

Read more

Biocon Sdn Bhd enters Malaysia Book of Records

Read more

India’s medicine watchdog under the scanner once again

Read more

Biocon Biologics denies bribery allegations

Read more

Biocon Biologics and Viatris launch Abevmy in Canada

Read more

CCI approves Serum Institute Life Sciences-Biocon Biologics deal

Read more

Biocon Q4FY22 revenue at Rs 2,476 crores, up 21 per cent

Read more

MoH, Malaysia, awards three-year contract to Biocon Biologics’s Insugen

Read more

Biocon Biologics’ partner receives positive EU CHMP opinion for biosimilar human insulin for IV infusion

Read more